[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341948-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341948-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","rna-seq-and-bulk-rna-seq-data-analysis-of-cancer-related-fibroblasts-caf-in-luad-to-construct-a-caf-based-risk-signature","RNA-seq and bulk RNA-seq data analysis of cancer-related fibroblasts (CAF) in LUAD to construct a CAF-based risk signature","","Cancer-associated fibroblasts (CAFs) drive angiogenesis, metastasis, and therapy resistance in lung adenocarcinoma (LUAD). A CAF-based risk signature was developed to predict LUAD prognosis using CAF characteristics. Signal-cell RNA-seq data were obtained from GEO, while bulk RNA-seq and microarray data came from GEO and TCGA. Seurat-based analysis identified CAF markers, differential expression, prognostic genes via Pearson correlation and Cox regression, and an 8-gene Lasso signature. Five CAF clusters were defined, with four prognostic. Pathway enrichment involved antigen processing and presentation, apoptosis, and cell cycle, and the signature linked with stromal/immune scores and immune cells, acting as an independent prognostic factor. A nomogram integrating stage and signature improved outcome prediction and supported immunotherapy response assessment.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/rna-seq-and-bulk-rna-seq-data-analysis-of-cancer-related-fibroblasts-caf-in-luad-to-construct-a-caf-based-risk-signature/341948/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/rna-seq-and-bulk-rna-seq-data-analysis-of-cancer-related-fibroblasts-caf-in-luad-to-construct-a-caf-based-risk-signature/341948.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How were LUAD single-cell and bulk RNA-seq datasets obtained for this study?","Question",{"text":63,"@type":64},"Signal-cell RNA-seq data were collected from the GEO database. Bulk RNA-seq and microarray data for LUAD were gathered from both GEO and TCGA.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What analytical steps were used to build the CAF-based risk signature?",{"text":68,"@type":64},"Differential expression analysis identified DEGs across normal and tumor samples in TCGA. Prognostic genes were found using Pearson correlation, followed by univariate Cox regression. Lasso regression then generated an 8-gene risk signature based on CAF-related prognostic genes.",{"name":70,"@type":61,"acceptedAnswer":71},"What main prognostic and immunotherapy-related findings were reported?",{"text":72,"@type":64},"Five CAF clusters were identified in LUAD, with four associated with prognosis. The 8-gene signature correlated with stromal and immune scores and immune cell profiles, and multivariate analysis indicated it was an independent prognostic factor, supporting prediction of immunotherapeutic outcomes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341948,1790170668,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nRNA-seq and bulk RNA-seq data analysis of cancer-related fibroblasts (CAF) in LUAD to construct a CAF-based risk signature  \nYoujiao Si1, Zhonghua Zhao2, Xiangjiao Meng3 & Kaikai Zhao3􀀍  \nAngiogenesis, metastasis, and resistance to therapy are all facilitated by cancer-associated fibroblasts (CAFs). A CAF-based risk signature can be used to predict patients’ prognoses for Lung adenocarcinoma (LUAD) based on CAF characteristics. The Gene Expression Omnibus (GEO) database was used to gather signal-cell RNA sequencing (scRNA-seq) data for this investigation. The GEO and TCGA databases were used to gather bulk RNA-seq and microarray data for LUAD. The scRNAseq data were analyzed using the Seurat R program based on the CAF markers. Our goal was to use differential expression analysis to discover differentially expressed genes (DEGs) across normal and tumor samples in theTCGA dataset. Pearson correlation analysis was utilized to discover prognostic genes related with CAF, followed by univariate Cox regression analysis. Using Lasso regression, a risk signature based on CAF-related prognostic genes was created. A nomogram model was created based on the clinical and pathological aspects. 5 CAF clusters were identified in LUAD, 4 of which were associated with prognosis. From 2811 DEGs, 1002 genes were found to be significantly correlated with CAF clusters, which led to the creation of a risk signature with 8 genes. These 8 genes were primarily connected with 41 pathways, such as antigen paocessing and presentation, apoptosis, and cell cycle. Meanwhile, the risk signature was significantly associated with stromal and immune scores, as well as some immune cells. Multivariate analysis revealed that risk signature was an independent prognostic factor for LUAD, and its value in predicting immunotherapeutic outcomes was confirmed. A novel nomogram integrating the stage and CAF-based risk signature was constructed, which exhibited favorable predictability and reliability in the prognosis prediction of LUAD. CAF-based risk signatures can be effective in predicting the prognosis of LUAD, and they may provide new strategies for cancer treatments by interpreting the response of LUAD to immunotherapy.  \nKeywords Lung adenocarcinoma, Cancer-associated fibroblasts, Immunotherapy, Nomogram  \nAbbreviations  \nNSCLCLUAD  \nICIs  \nTME  \nCAFs ScRNA-seq GEO  \nUMI  \nTCGA  \nNon-small cell lung cancer Lung adenocarcinoma Immune-checkpoint inhibitors Tumor microenvironment Cancer associated fibroblasts  \nScRNA-seq Single-cell RNA-sequencing Gene Expression Omnibus  \nUnique Molecular Identifier The Cancer Genome Atlas  \n1Department of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandong, China. 2Department of Oncology, Binzhou Medical University Hospital, Binzhou, Shandong, China. 3Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandong, China. 􀀍 email: [abcdkaikai35@126.com](abcdkaikai35@126.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nSNV  \nCNV  \nKEGG  \nDEGs  \nFDR  \nROC  \nDCA  \nICBCDC25CEXO1 CCNB1 DPYSL2 METTL7ACLEC3BBTK  \nGRIA  \nSingle-nucleotide variant Copy number variant  \nKyoto Encyclopedia of Genes and Genome Differentially expressed genes  \nFalse discovery rate  \nReceiver operating characteristic curve Decision curve analysis  \nImmune checkpoint blocks Cell division cycle 25 C Exonuclease 1  \nCell cycle-related proteins cyclin B1 Dihydropyrimidinase-like 2  \nMethyltransferase like 7 A  \nC-Type Lectin Domain Family 3 Member BBrutons tyrosine kinase  \nGlutamate receptor  \nLung cancer is estimated to contribute to 25% of cancer-associated deaths, and non-small cell lung cancer (NSCLC) alone accounts for 85% of cases1, lung adenocarcinoma (LUAD) and squ","cbCaipqbs2YmavHK","https://ap.wps.com/l/cbCaipqbs2YmavHK","pdf",8366827,14,"English","# Introduction\n# Tumor Microenvironment and CAFs\n# Data Sources and Analytical Workflow\n## Differential Expression and Prognostic Gene Selection\n## Signature Construction and Validation\n# CAF Clustering and Biological Pathways\n# Risk Signature, Immune Features, and Prognostic Value\n# Nomogram and Clinical Utility","[{\"question\":\"How were LUAD single-cell and bulk RNA-seq datasets obtained for this study?\",\"answer\":\"Signal-cell RNA-seq data were collected from the GEO database. Bulk RNA-seq and microarray data for LUAD were gathered from both GEO and TCGA.\"},{\"question\":\"What analytical steps were used to build the CAF-based risk signature?\",\"answer\":\"Differential expression analysis identified DEGs across normal and tumor samples in TCGA. Prognostic genes were found using Pearson correlation, followed by univariate Cox regression. Lasso regression then generated an 8-gene risk signature based on CAF-related prognostic genes.\"},{\"question\":\"What main prognostic and immunotherapy-related findings were reported?\",\"answer\":\"Five CAF clusters were identified in LUAD, with four associated with prognosis. The 8-gene signature correlated with stromal and immune scores and immune cell profiles, and multivariate analysis indicated it was an independent prognostic factor, supporting prediction of immunotherapeutic outcomes.\"}]","RNA-seq and bulk RNA-seq data analysis of cancer-related fibroblasts (CAF) in LUAD to construct a CAF-based risk signature | PDF",1790044457,35,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e17a6279bed3e7bd025c005df4fbe7e4.webp",983,1291,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0d40585a571e827872c80a1c06ac2ad.webp",982,1290,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e1972f57cf1e049f7a2d29df8827a16.webp",981,1289,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f88e9a4ff9d3363459124368718b81e8.webp",980,1287]